sars-cov-2

Documents about sars-cov-2

• Host metabolic responses to SARS-CoV-2 and influenza viruses: parallels and contrasts.#258121NCBI PubMed Central
• Analogs of NIH Molecular Probe ML283 Are Potent SARS-CoV-2 Helicase Inhibitors.#295425NCBI PubMed Central
• SARS-CoV-2 Infection, Vaccination Status, and Dementia Risk: A Nested Case-Control Study.#298699NCBI PubMed Central
• Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents#325133ClinicalTrials.gov
• Fase I Clinical Trial on NK Cells for COVID-19#390958ClinicalTrials.gov
• Rapid Determination of SARS-CoV-2 antibodies using a bedside, point-of-Care, serological test#391821HAL (France)
• SARS-CoV-2 Introductions into Lao PDR Revealed by Genomic Surveillance, 2021–2024#427131Europe PMC
• SARS-CoV-2 NSP8-Derived Peptide Effectively Suppresses the Activity of Helicase NSP13.#427698NCBI PubMed Central
• Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers#432935ClinicalTrials.gov
• Complex intra-host SARS-CoV-2 evolution following monoclonal antibody pre-exposure prophylaxis#451904Europe PMC
• Biomarkers of protection against controlled human SARS-CoV-2 Delta variant breakthrough infection#475766Europe PMC
• DISulfiram for COvid-19 (DISCO) Trial#801592ClinicalTrials.gov
• MxA-Guided Antiviral Treatment in Respiratory Viral Infections#804883ClinicalTrials.gov
• COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults (Dyn3CEA_Nosocor)#832027ClinicalTrials.gov
• Consequences in ICU of Vaccination Status of Covid-19 Patients#848412ClinicalTrials.gov
• PROLIFIC ChemoprophylaxisTrial (COVID-19)#849567ClinicalTrials.gov
• Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19#850551ClinicalTrials.gov
• Effectiveness Evaluation of the Sinopharm Vaccine in the Dondo District in Mozambique#868027ClinicalTrials.gov
• To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects#877199ClinicalTrials.gov
• Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.#683130ClinicalTrials.gov
• Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT, SPIKEVAX X Injection, SPIKEVAX JN Injection and SPIKEVAX IN PRE-FILLED SYRINGE#840130ClinicalTrials.gov
• Emergence of the SARS‐CoV‐2 B.1.1.7 variant observed at the Poitiers University Hospital#175702HAL (France)
• Tuning Proton Transfer Thermodynamics in SARS-CoV-2 Main Protease: Implications for Catalysis and Inhibitor Design#315083HAL (France)
• Why Andes hantavirus is not the next SARS-CoV-2: contrasting viral shedding, transmissibility and genomic patterns#652840HAL (France)
• Molecular epidemiology of SARS-CoV-2 in Northern South Africa : wastewater surveillance from January 2021 to May 2022#240970SUNScholar
• Crystallographic fragment screening against SARS‐CoV‐2 nonstructural protein 1 using the F2X‐Entry Screen and a newly developed fragment library#287769edoc-Server
• Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19#834381ClinicalTrials.gov
• Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients#872159ClinicalTrials.gov
• Effectiveness of Covid-19 Vaccination in Eswatini Against SARS-CoV-2 Associated Hospitalization and Death#28444ClinicalTrials.gov
• When Viruses Talk through Extracellular Vesicles: a New Perspective on Sars-Cov-2-Induced Neurodegeneration.#148075NCBI PubMed Central
• Inhibitors Targeting SARS-CoV-2 Papain-Like Protease: Screening, Design, Synthesis, and Biological Evaluation.#170745NCBI PubMed Central
• Safety and Tolerability of COVID-19 Vaccine (ABNCoV2)#184938ClinicalTrials.gov
• SARS CoV 2 Associated Shifts in the Upper Respiratory Tract Mycobiome in Non Hospitalized Cases#267878bioRxiv / medRxiv
• Genomic surveillance in Morocco tracks SARS-CoV-2 variant shift from Alpha to Omicron sublineage JN1#288291HAL (France)
• Consider autoimmune encephalitis in cases of headache, dizziness, and mild pleocytosis following SARS-CoV-2 infection#291895HAL (France)
• Dissecting serum polyclonal antibody escape to SARS-CoV-2 variants by deep mutational learning.#298802NCBI PubMed Central
• Exploring Key Regulators of Mitochondrial Dynamics and Immune Response in SARS-CoV-2 Infection.#317846NCBI PubMed Central
• Repurposing Candidate Drugs to Prevent SARS-CoV-2: A PharmLines Test-Negative Case–Control Study.#317955NCBI PubMed Central
• Structure-Guided Design of Proteomimetics Targeting the SARS-CoV-2 S-RBD/hACE2 Interface.#322968NCBI PubMed Central
• Self-priming hairpin probe-utilized isothermal amplification reaction for SARS-CoV-2 detection#374915KOASAS: KAIST Open Access Self-Archiving System
• Cascaded microfiber biosensor for simultaneous detection of dengue and SARS-CoV-2 viruses#441205Universiti Putra Malaysia Institutional Repository
• Extensive splanchnic vein thrombosis after SARS-CoV-2 vaccination: A Vascular Liver Disease Group (VALDIG) initiative#676815HAL (France)
• Fluvoxamine Administration in Moderate SARS-CoV-2 (COVID-19) Infected Patients#803064ClinicalTrials.gov
• Clustering based magnetic assays for SARS-CoV-2 detection with scFv-functionalized magnetic nanoparticles#808829arXiv (OAI Expanded)
• Clustering based magnetic assays for SARS-CoV-2 detection with scFv-functionalized magnetic nanoparticles#818821arXiv (All)
• Pancoronavirus Vaccine Study in Healthy Adults#825883ClinicalTrials.gov
• Highly Adsorptive Au-TiO2 Nanocomposites for the SERS Face Mask Allow the Machine-Learning-Based Quantitative Assay of SARS-CoV-2 in Artificial Breath Aerosols#337787KOASAS: KAIST Open Access Self-Archiving System
• Temporal dynamics of SARS-CoV-2 lineages in Santa Catarina, Brasil: genomic data analysis before and during the year following the first officially reported case of Omicron#614827Figshare
• COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C#826416ClinicalTrials.gov
• Explainable Convolutional Neural Network Model Provides an Alternative Genome-Wide Association Perspective on Mutations in SARS-CoV-2#355129ODU Digital Commons